available on the EMA website. Make a checklist that includes:

• Type of submission (ICSR, PSUR, etc.)
• Document format requirements (XML, PDF, etc.)
• Deadlines and timelines for submissions
• Special cases or exemptions

In this stage, consult your pharmacovigilance service provider to clarify any specifics needed for compliance, especially if your organization is new to the IRIS submission system.

Step 2: Setting Up Your IRIS Account

Creating an account on the IRIS platform is a prerequisite for making submissions. The process involves a few straightforward steps:

1. Navigate to the IRIS portal.
2. Click on the ‘Register’ option to initiate account setup.
3. Fill in the required information including your organization details, contact information, and any relevant registration numbers.
4. Submit the registration form and await verification from the EMA.

Once your account is confirmed, ensure that all associated users have appropriate access rights based on their roles within your organization. Use access management tools in the IRIS platform to add or remove users as necessary.

Step 3: Understanding Submission Types and Data Fields

The IRIS platform allows for multiple types of submissions related to pharmacovigilance. Familiarize yourself with the submission types so you can accurately and efficiently fill in the required data fields. Important submission types include:

• Individual Case Safety Reports (ICSRs): Mandatory for reporting serious adverse events.
• Periodic Safety Update Reports (PSURs): Required for summarizing data on the safety of a drug over a specified timeframe.
• Risk Management Plans (RMPs): Outlines risk minimization processes and strategies.

It is vital to read the IRIS user manual provided by the EMA for insights on each submission type’s data fields and requirements. Make a detailed layout of required fields to ensure no detail is overlooked. This preparation phase significantly reduces potential queries or issues during the actual submission.

Step 4: Preparing Submission Documents and Data Packages

After determining the submission requirements and the necessary data fields, the next step involves preparing the submission documents. Each type of submission will require different document templates, usually outlined in the EMA guidelines. This is typically where many organizations require robust support from their chosen pharmacovigilance service provider.

Key steps in this phase include:

1. Document creation: Utilize the approved templates and guidelines to draft each document needed for submission.
2. Data validation: Run data checks to validate completeness and compatibility with the IRIS platform. Utilize validation tools that conform to industry standards, ensuring your data packages are compliant.
3. Quality assurance review: Engage the quality assurance team to ensure compliance with all documentation standards. They should review for accuracy, spelling errors, and regulatory compliance.

After finalizing the documents, collate them into packages defined by IRIS requirements. If in doubt, seek assistance from regulatory compliance firms that specialize in these submissions to ensure you meet all regulatory expectations before proceeding to the submission stage.

Step 5: Executing the Submission through IRIS

With accounts set up, documents prepared, and data validated, you are positioned to execute the submission via the IRIS platform. Follow these steps diligently to ensure a successful submission:

1. Log into the IRIS platform with your organizational credentials.
2. Select the appropriate type of submission from the main menu based on your preparations.
3. Upload the relevant documents adhering to the specified format requirements.
4. Fill in all necessary data fields that you prepared earlier. Ensure all entries are accurate and complete.
5. Review your submission online. The IRIS platform provides a summary and highlights incomplete sections that need attention. Resolve any issues indicated.
6. Once reviewed, click on the ‘Submit’ button to file your submission officially.

Upon submission, ensure to save or create a digital record of your submission confirmation number to track your submission status. You may also want to monitor the submission progress through the IRIS platform post-submission.

Step 6: Tracking Submission Status and Responding to Queries

Following submission through the IRIS platform, continuous monitoring of the status is essential. The IRIS system allows users to track their submissions and view changes that may arise during the review period. Follow these steps:

1. Regularly log into the IRIS platform to check the status of your submission.
2. Utilize the ‘Submission Tracking’ feature to view detailed progress indicators.
3. If queries arise, prepare to respond promptly. FAQ sections are usually provided for common queries.

In instances where further clarification is requested by the regulatory body, respond quickly with the necessary information required. Delays in response may affect the overall timeline of drug approval or required modifications to your pharmacovigilance activities.

Step 7: Keeping Records and Post-Submission Compliance

Post-submission, it is a best practice to maintain detailed records of all submissions made through the IRIS platform, including documents uploaded, submission confirmations, and any communications received from the regulatory body. This diligence is crucial for regulatory compliance and conducting audits. Key practices include:

• Document Management: Utilize document management systems to archive all submission-related documents systematically.
• Auditing: Conduct regular audits to ensure compliance with submission protocols and readiness for any regulatory inspections.
• Review Processes: Implement regular reviews of submitted data and outcomes to refine submission strategies for future filings.

These practices will not only facilitate smoother future submissions but also foster a culture of transparency and compliance within your organization, further solidifying your standing with regulatory bodies and health organizations.

Conclusion: Enhancing Submission Efficiency through IRIS

In summary, submitting through the IRIS platform is a vital process for regulatory, QA, clinical, and medical affairs teams to ensure robust pharmacovigilance service delivery. By following this step-by-step tutorial, teams will increase submission efficiency and compliance with EMA regulations.

Leveraging the IRIS platform effectively is vital for any industry professional involved in regulatory submissions within the EU. The steps outlined above are designed to facilitate a systematic approach, ensuring compliance with the broad regulatory framework established by agencies such as the EMA and WHO.

To maximize the effectiveness and timeliness of your submissions, consider investing in training sessions and resources provided by pharmacovigilance services or regulatory compliance firms. This proactive approach not only enhances team competency but also minimizes delays and errors in future submissions.